HIV- 1 transmissionshyppigheden var ens lav i begge behandlingsgrupper (1, 3% i VIRAMUNE gruppen, 1, 4% i placebogruppen).
HIV-1 transmission rates were similarly low in both treatment groups (1.3% in the VIRAMUNE group, 1.4% in the placebo group).